Effects of angiotensin-converting enzyme gene polymorphism and serum vitamin D levels on ambulatory blood pressure measurement and left ventricular mass in Turkish hypertensive population

Blood Pressure Monitoring

Volumn 12, Issue 4, 2007, Pages 207-213

  Kulah, Eyup ^a   Dursun, Ahmet ^a   Aktunc, Erol ^a   Acikgoz, Serefden ^a   Aydin, Mustafa ^a   Can, Murat ^a   Dursun, Aydn ^a  

^a ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

Author keywords

24 h ambulatory blood pressure measurement; ACE gene; Left ventricular hypertrophy; Vitamin D

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; VITAMIN D;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CORRELATION ANALYSIS; DISEASE DURATION; DNA POLYMORPHISM; ECHOCARDIOGRAPHY; FEMALE; GENOTYPE; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PATIENT ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETINA EXAMINATION; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; VITAMIN BLOOD LEVEL;

ADULT; ALLELES; BLOOD PRESSURE; CIRCADIAN RHYTHM; FEMALE; HEART VENTRICLES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RETINAL VESSELS; RISK FACTORS; TURKEY; VITAMIN D;

EID: 34548443774     PISSN: 13595237     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBP.0b013e32813fa371     Document Type: Article

References (52)

1. Ward R. Familial aggregation and genetic epidemiology of blood pressure. In: Laragh J, Brenner B, editors. In hypertension: pathophysiology, diagnosis and management. 2nd ed. New York: Raven Publishers; 1995: pp. 67-86.
2. Dzau VJ. Tissue renin-angiotensin system in myocardial hypertrophy and failure. Arch Intern Med 1993; 153:937-942.
3. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86:1343-1346.
4. Danser AH, Schalekamp MA, Bax WA, van den Brink AM, Saxena PR, Riegger GA, et al. Angiotensin-converting enzyme in the human heart: effect of the deletion/insertion polymorphism. Circulation 1995; 92: 1387-1388.
5. Zee RY, Lou YK, Griffiths LR, Morris BJ. Association of a polymorphism of the angiotensin I-converting enzyme gene with essential hypertension. Biochem Biophys Res Commun 1992; 184:9-15.
6. Rutledge DR, Kubilis P, Browe CS, Ross EA. Polymorphism of the angiotensin I converting enzyme gene in essential hypertensive patients. Biochem Mol Biol Int 1995; 35:661-668.
7. Jeunemaitre X, Lifton RP, Hunt SC, Williams RR, Lalouel JM. Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nat Genet 1992; 1:72-75.
8. Higashimori K, Zhao Y, Higaki J, Kamitani A, Katsuya T, Nakura J, et al. Association analysis of a polymorphism of the angiotensin converting enzyme gene with essential hypertension in the Japanese population. Biochem Biophys Res Commun 1993; 191:399-404.
9. Schunkert H, Hense HW, Holmer SR, Stender M, Perz S, Keil U, et al. Association between a deletion polymorphism of the angiotensin- converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 1994; 330:1634-1638.
10. Lindpaintner K, Lee M, Larson MG, Rao VS, Pfeffer MA, Ordovas JM, et al. Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N Engl J Med 1996; 334:1023-1028.
11. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359:641-644.
12. Kristal-Boneh E, Froom P, Harari G, Ribak J. Association of calcitriol and blood pressure in normotensive men. Hypertension 1997; 30:1289-1294.
13. Lind L, Hanni A, Lithell H, Hvarfner A, Sorensen OH, Ljunghall S. Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am J Hypertens 1995; 8:894-901.
14. Pfeifer M, Begerow B, Minne HW, Nachtigall D, Hansen C. Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab 2001; 86:1633-1637.
15. Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W, Kong J. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol 2004; 89-90:387-392.
16. Zakopoulos N, Stamatelopoulos S, Toumanidis S, Saridakis N, Trika C, Moulopoulos S. 24 h blood pressure profile affects the left ventricle independently of the pressure level. A study in untreated essential hypertension diagnosed by office blood pressure readings. Am J Hypertens 1997; 10:168-174.
17. Moulopoulos SD, Stamatelopoulos SF, Zakopoulos NA, Toumanides SA, Nanas S, Papadakis JA, et al. Effect of 24 h blood pressure and heart rate variations on left ventricular hypertrophy and dilatation in essential hypertension. Am Heart J 1990; 119:1147-1152.
18. Boley E, Pickering TG, James GD, de Simone G, Roman MJ, Devereux RB. Relations of ambulatory blood pressure level and variability to left ventricular and arterial function and to left ventricular mass in normotensive and hypertensive adults. Blood Press Monit 1997; 2:323-331.
19. Zakopoulos NA, Lekakis JP, Papamichael CM, Toumanidis ST, Kanakakis JE, Kostandonis D, et al. Pulse pressure in normotensives: a marker of cardiovascular disease. Am J Hypertens 2001; 14:195-199.
20. Zachariah PK, Sheps SG, Ilstrup DM, Long CR, Bailey KR, Wiltgen CM, et al. Blood pressure load: a better determinant of hypertension. Mayo Clin Proc 1988; 63:1085-1091.
21. Mancia G, Zanchetti A, Agabiti-Rosei E, Benemio G, De Cesaris R, Fogari R, et al. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on ambulatory monitoring of blood pressure and lisinopril evaluation. Circulation 1997; 95:1464-1470.
22. Devereux RB, Casale PN, Kligfield P, Eisenberg RR, Miller D, Campo E, et al. Performance of primary and derived M-mode echocardiographic measurements for detection of left ventricular hypertrophy in necropsied subjects and in patients with systemic hypertension, mitral regurgitation and dilated cardiomyopathy. Am J Cardiol 1986; 57:1388-1393.
23. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med 1990; 322:1561-1566.
24. Keith NM, Wagener HP, Barker NW. Some different types of essential hypertension: their course and prognosis. Am J Med Sci 1974; 268:336-345.
25. O'Donnell CJ, Lindpaintner K, Larson MG, Rao VS, Ordovas JM, Schaefer EJ, et al. Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation 1998; 97:1766-1772.
26. Markus HS, Barley J, Lunt R, Bland JM, Jeffery S, Carter ND, et al. Angiotensin-converting enzyme gene deletion polymorphism. A new risk factor for lacunar stroke but not carotid atheroma. Stroke 1995; 26:1329-1333.
27. Zee RY, Griffiths LR, Morris BJ. Marked association of a RFLP for the low density lipoprotein receptor gene with obesity in essential hypertensives. Biochem Biophys Res Commun 1992; 189:965-971.
28. Kario K, Kanai N, Nishiuma S, Fujii T, Saito K, Matsuo T, et al. Hypertensive nephropathy and the gene for angiotensin-converting enzyme. Arterioscler Thromb Vasc Biol 1997; 17:252-256.
29. Pontremoli R, Sofia A, Tirotta A, Ravera M, Nicolella C, Viazzi F, et al. The deletion polymorphism of the angiotensin I-converting enzyme gene is associated with target organ damage in essential hypertension. J Am Soc Nephrol 1996; 7:2550-2558.
30. Staessen JA, Ginocchio G, Wang JG, Saavedra AP, Soubrier F, Vlietinck R, et al. Genetic variability in the renin-angiotensin system: prevalence of alleles and genotypes. J Cardiovasc Risk 1997; 4:401-422.
31. Perticone F, Ceravolo R, Cosco C, Trapasso M, Zingone A, Malatesta P, et al. Deletion polymorphism of angiotensin converting enzyme gene and left ventricular hypertrophy in southern Italian patients. J Am Coll Cardiol 1997; 29:365-369.
32. Celentano A, Mancini FP, Crivaro M, Palmieri V, Ferrara LA, De Stefano V, et al. Cardiovascular risk factors, angiotensin-converting enzyme gene I/D polymorphism, and left ventricular mass in systemic hypertension. Am J Cardiol 1999; 83:1196-1200.
33. Perticone F, Maio R, Cosco C, Ceravolo R, Iacopino S, Chello M, et al. Hypertensive left ventricular remodeling and ACE-gene polymorphism. Cardiovasc Res 1999; 43:192-199.
34. Jian M, Cao X, Huang J, Qi J, Liu G, Wang J, et al. Polymorphism of angiotensin I converting enzyme gene in the older Chinese: linked to ambulatory blood pressure levels and circadian blood pressure rhythm. Int J Cardiol 1996; 55:33-40.
35. Celentano A, Mancini FP, Crivaro M, Palmieri V, De Stefano V, Ferrara LA, et al. Influence of cardiovascular risk factors on relation between angiotensin converting enzyme-gene polymorphism and blood pressure in arterial hypertension. J Hypertens 1998; 16:985-991.
36. Matsubara M, Suzuki M, Fujiwara T, Kikuya M, Metoki H, Michimata M, et al. Angiotensin-converting enzyme I/D polymorphism and hypertension: the Ohasama study. J Hypertens 2002; 20:1121-1126.
37. Fornage M, Amos CI, Kardia S, Sing CF, Turner ST, Boerwinkle E. Variation in the region of the angiotensin-converting enzyme gene influences interindividual differences in blood pressure levels in young white males. Circulation 1998; 97:1773-1779.
38. Karjalainen J, Kujala UM, Stolt A, Mantysaari M. Angiotensinogen gene M235 T polymorphism predicts left ventricular hypertrophy in endurance athletes. J Am Coll Cardiol 1999; 34:494-499.
39. Ledru F, Blanchard D, Battaglia S, Jeunemaitre X, Courbon D, Guize L, et al. Relation between severity of coronary artery disease, left ventricular function and myocardial infarction, and influence of the ACE I/D gene polymorphism. Am J Cardiol 1998; 82:160-165.
40. Lechin M, Quinones MA, Orman A. Angiotensin I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. Circulation 1995; 92:1808-1812.
41. Di Pasquale P, Cannizzaro S, Scalzo S, Giubilato A, Maringhini G, Giambanco F, et al. Relationship between ACE-DD polymorphism and diastolic performance in healthy subjects. Scand Cardiovasc J 2004; 38:93-97.
42. Celentano A, Mancini FP, Crivaro M, Palmieri V, Ferrara LA, De Stefano V, et al. Cardiovascular risk factors, angiotensin-converting enzyme gene I/D polymorphism, and left ventricular mass in systemic hypertension. Am J Cardiol 1999; 83:1196-1200.
43. Busjahn A, Knoblauch H, Knoblauch M, Bohlender J, Menz M, Faulhaber HD, et al. Angiotensin-converting enzyme and angiotensinogen gene polymorphisms, plasma levels, cardiac dimensions. A twin study. Hypertension 1997; 29:165-170.
44. Katwa LC, Ratajska A, Cleutjens JP, Sun Y, Zhou G, Lee SJ, et al. Angiotensin converting enzyme and kininase-II-like activities in cultured valvular interstitial cells of the rat heart. Cardiovasc Res 1995; 29:57-64.
45. Brilla CG, Maisch B. Regulation of the structural remodelling of the myocardium: from hypertrophy to heart failure. Eur Heart J 1994; 15 (Suppl D):45-52.
46. Lekakis JP, Zakopoulos NA, Protogerou AD, Kotsis VT, Papaioannou TG, Stamatelopoulos KS, et al. Cardiac hypertrophy in hypertension: relation to 24 h blood pressure profile and arterial stiffness. Int J Cardiol 2004; 97:29-33.
47. Feola M, Boffano GM, Procopio M, Reynaud S, Allemano P, Rizzi G. Ambulatory 24 h blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients. G Ital Cardiol 1998; 28:38-44.
48. Devereux RB, Pickering TG, Harshfield GA, Kleinert HD, Denby L, Clark L, et al. Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stress. Circulation 1983; 68:470-476.
49. Mancia G, Parati G, Albini F, Villani A. Circadian blood pressure variations and their impact on disease. J Cardiovasc Pharmacol 1988; 12 (Suppl 7):S11-S17.
50. Shimada K, Kawamoto A, Matsubayashi K, Nishinaga M, Kimura S, Ozawa T. Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension. J Hypertens 1992; 10:875-878.
51. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 1994; 24:793-801.
52. Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation 2005; 111:1777-1783.